Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 16
1952 8
1953 5
1954 2
1955 1
1956 3
1957 2
1958 3
1959 6
1960 3
1961 6
1962 5
1963 2
1964 6
1965 8
1966 7
1967 5
1968 7
1969 12
1970 15
1971 13
1972 11
1973 6
1974 4
1975 8
1976 7
1977 6
1978 8
1979 10
1980 5
1981 10
1982 20
1983 10
1984 22
1985 9
1986 9
1987 11
1988 13
1989 7
1990 10
1991 12
1992 7
1993 4
1994 8
1995 4
1996 4
1997 3
1998 1
1999 6
2000 4
2001 3
2002 4
2003 2
2004 14
2005 3
2006 4
2007 2
2008 2
2009 1
2010 1
2011 1
2012 2
2013 5
2014 7
2015 4
2016 3
2017 4
2018 2
2019 2
2020 2
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

441 results
Results by year
Filters applied: . Clear all
Page 1
Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment.
Vivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, Shafer B, Peck A, Sivils K, Rasmussen A, Chiorini JA, He J, Ambrus JL Jr. Vivino FB, et al. Among authors: ambrus jl jr. Clin Immunol. 2019 Jun;203:81-121. doi: 10.1016/j.clim.2019.04.009. Epub 2019 Apr 29. Clin Immunol. 2019. PMID: 31022578 Review. No abstract available.
Disruption of RFX family transcription factors causes autism, attention-deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior.
Harris HK, Nakayama T, Lai J, Zhao B, Argyrou N, Gubbels CS, Soucy A, Genetti CA, Suslovitch V, Rodan LH, Tiller GE, Lesca G, Gripp KW, Asadollahi R, Hamosh A, Applegate CD, Turnpenny PD, Simon MEH, Volker-Touw CML, Gassen KLIV, Binsbergen EV, Pfundt R, Gardeitchik T, Vries BBA, Immken LL, Buchanan C, Willing M, Toler TL, Fassi E, Baker L, Vansenne F, Wang X, Ambrus JL Jr, Fannemel M, Posey JE, Agolini E, Novelli A, Rauch A, Boonsawat P, Fagerberg CR, Larsen MJ, Kibaek M, Labalme A, Poisson A, Payne KK, Walsh LE, Aldinger KA, Balciuniene J, Skraban C, Gray C, Murrell J, Bupp CP, Pascolini G, Grammatico P, Broly M, Küry S, Nizon M, Rasool IG, Zahoor MY, Kraus C, Reis A, Iqbal M, Uguen K, Audebert-Bellanger S, Ferec C, Redon S, Baker J, Wu Y, Zampino G, Syrbe S, Brosse I, Jamra RA, Dobyns WB, Cohen LL, Blomhoff A, Mignot C, Keren B, Courtin T, Agrawal PB, Beggs AH, Yu TW. Harris HK, et al. Among authors: ambrus jl jr. Genet Med. 2021 Jun;23(6):1028-1040. doi: 10.1038/s41436-021-01114-z. Epub 2021 Mar 3. Genet Med. 2021. PMID: 33658631
Inflammatory Joint Diseases.
Shi G, Ambrus JL, Ye S, Shen L. Shi G, et al. Among authors: ambrus jl. Biomed Res Int. 2015;2015:973510. doi: 10.1155/2015/973510. Epub 2015 May 21. Biomed Res Int. 2015. PMID: 26090466 Free PMC article. No abstract available.
Biologics in systemic sclerosis.
Xuan J, Shen L, Zhang C, Ambrus JL Jr. Xuan J, et al. Among authors: ambrus jl jr. Curr Pharm Biotechnol. 2014;15(6):549-57. doi: 10.2174/138920101506140910150749. Curr Pharm Biotechnol. 2014. PMID: 25213364 Review.
Burkitt's lymphoma.
Ambrus JL, Ambrus CM. Ambrus JL, et al. J Med. 1981;12(6):385-413. J Med. 1981. PMID: 6274988 Review.
Update on the use of biologics in vasculitides.
Vishwanath S, Relan M, Shen L, Ambrus JL Jr. Vishwanath S, et al. Among authors: ambrus jl jr. Curr Pharm Biotechnol. 2014;15(6):558-62. doi: 10.2174/138920101506140910151126. Curr Pharm Biotechnol. 2014. PMID: 25213365 Review.
Update on the use of biologics in lupus.
Relan M, Vishwanath S, Shen L, Ambrus JL Jr. Relan M, et al. Among authors: ambrus jl jr. Curr Pharm Biotechnol. 2014;15(6):516-20. doi: 10.2174/1389201015666140804162053. Curr Pharm Biotechnol. 2014. PMID: 25091119 Review.
441 results